R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_mood Arg1:T3 Arg2:T4	
R3	AND Arg1:T5 Arg2:T6	
R4	Has_value Arg1:T7 Arg2:T8	
R5	Has_index Arg1:T14 Arg2:T15	
R6	Has_mood Arg1:T20 Arg2:T21	
R7	multi Arg1:T19 Arg2:T20	
R8	Has_index Arg1:T18 Arg2:T19	
R9	Has_temporal Arg1:T17 Arg2:T18	
R10	AND Arg1:T17 Arg2:T16	
R11	Has_temporal Arg1:T13 Arg2:T14	
*	OR T7 T9 T13 T17 T12 T11 T10
R12	Subsumes Arg1:T5 Arg2:T7	
R13	Subsumes Arg1:T3 Arg2:T7	
R14	AND Arg1:T26 Arg2:T27	
*	OR T29 T30
R15	Subsumes Arg1:T28 Arg2:T29	
*	OR T28 T31
*	OR T35 T36
*	OR T33 T34
R16	Subsumes Arg1:T33 Arg2:T35	
R18	Has_qualifier Arg1:T41 Arg2:T42	
R17	AND Arg1:T40 Arg2:T39	
R19	Subsumes Arg1:T40 Arg2:T41	
R20	AND Arg1:T45 Arg2:T46	
*	OR T47 T48 T49 T50
R21	Subsumes Arg1:T45 Arg2:T47	
R22	Has_qualifier Arg1:T53 Arg2:T54	
R23	Subsumes Arg1:T60 Arg2:T56	
*	OR T55 T60
R24	Subsumes Arg1:T53 Arg2:T55	
R25	Has_mood Arg1:T67 Arg2:T68	
R26	AND Arg1:T66 Arg2:T67	
*	OR T69 T72 T73 T71 T70
R27	Subsumes Arg1:T66 Arg2:T69	
R28	Has_temporal Arg1:T66 Arg2:T65	
*	OR T79 T78
R29	Has_qualifier Arg1:T79 Arg2:T77	
R30	Has_qualifier Arg1:T79 Arg2:T76	
*	OR T81 T82
R31	Subsumes Arg1:T79 Arg2:T81	
R32	Has_qualifier Arg1:T85 Arg2:T86	
R33	Subsumes Arg1:T60 Arg2:T57	
R34	Subsumes Arg1:T60 Arg2:T58	
R35	Subsumes Arg1:T60 Arg2:T59	
T1	Condition 21 35	progressive MS
T2	Qualifier 13 20	primary
T3	Procedure 62 65	MRI
T4	Mood 37 58	Inability to complete
T5	Condition 67 84	contraindications
T6	Procedure 89 92	MRI
T7	Measurement 127 133	weight
T8	Value 134 141	=140 kg
T9	Device 143 152	pacemaker
T10	Device 154 171	cochlear implants
T11	Device 185 214	foreign substances in the eye
T12	Device 216 243	intracranial vascular clips
T13	Procedure 245 252	surgery
T14	Temporal 253 291	within 6 weeks of entry into the study
T15	Reference_point 271 291	entry into the study
T16	Device 293 307	coronary stent
T17	Procedure 308 317	implanted
T18	Temporal 318 370	within 8 weeks prior to the time of the intended MRI
T19	Reference_point 342 370	the time of the intended MRI
T20	Procedure 367 370	MRI
T21	Mood 358 366	intended
T26	Condition 390 401	intolerance
T27	Drug 379 389	Gadolinium
T28	Condition 414 448	ischemic cerebrovascular disorders
T29	Condition 456 462	stroke
T30	Condition 464 489	transient ischemic attack
T31	Condition 494 521	ischemia of the spinal cord
T33	Condition 552 580;596 601	central nervous system (CNS) tumor
T34	Condition 584 601	spinal cord tumor
T35	Condition 609 619	meningioma
T36	Condition 621 627	glioma
T39	Condition 689 699	myelopathy
T40	Condition 669 685	metabolic causes
T41	Condition 717 739	vitamin B12 deficiency
T42	Qualifier 707 716	untreated
T45	Condition 771 788	infectious causes
T46	Condition 792 802	myelopathy
T47	Condition 810 818	syphilis
T48	Condition 820 832	Lyme disease
T49	Condition 834 871	human T-lymphotropic virus 1 (HTLV-1)
T50	Condition 873 897	herpes zoster myelopathy
T53	Condition 933 970	progressive CNS degenerative disorder
T54	Qualifier 911 932	genetically inherited
T55	Condition 978 1000	hereditary paraparesis
T56	Condition 1009 1031	mitochondrial myopathy
T57	Condition 1033 1047	encephalopathy
T58	Condition 1049 1064	lactic acidosis
T59	Condition 1066 1072	stroke
T60	Condition 1002 1007;1074 1082	MELAS syndrome
T64	Condition 1085 1105	Neuromyelitis optica
T65	Temporal 1107 1114	History
T66	Condition 1136 1165	systemic autoimmune disorders
T67	Condition 1186 1216	progressive neurologic disease
T68	Mood 1166 1185	potentially causing
T69	Condition 1224 1229	lupus
T70	Condition 1231 1266	anti-phospholipid antibody syndrome
T71	Condition 1268 1286	Sjogren's syndrome
T72	Condition 1288 1304	Beh√ßet's disease
T73	Condition 1306 1317	sarcoidosis
T76	Qualifier 1331 1337	severe
T77	Qualifier 1339 1361	clinically significant
T78	Condition 1371 1389	spinal cord trauma
T79	Condition 1362 1367;1383 1389	brain trauma
T81	Condition 1397 1415	cerebral contusion
T82	Condition 1417 1440	spinal cord compression
T85	Observation 1443 1462	Vulnerable patients
T86	Qualifier 1487 1567	Articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code
